{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:44:18Z","timestamp":1794703458983,"version":"4.9.1"},"reference-count":123,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1053\/j.seminoncol.2010.10.013","type":"journal-article","created":{"date-parts":[[2010,12,16]],"date-time":"2010-12-16T05:04:37Z","timestamp":1292475877000},"page":"580-590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Parathyroid Cancer"],"prefix":"10.1053","volume":"37","author":[{"given":"John M.","family":"Sharretts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Electron","family":"Kebebew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Simonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2010.10.013_bib1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00000658-196904000-00022","article-title":"Parathyroid carcinoma: a collective review","volume":"169","author":"Holmes","year":"1969","journal-title":"Ann Surg"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1210\/edrv-3-2-218","article-title":"Parathyroid carcinoma: a review of 62 patients","volume":"3","author":"Shane","year":"1982","journal-title":"Endocr Rev"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib3","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/BF01665308","article-title":"Diagnosis and treatment of patients with parathyroid carcinoma: an update and review","volume":"15","author":"Obara","year":"1991","journal-title":"World J Surg"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00005792-199207000-00002","article-title":"Parathyroid carcinoma: clinical and pathologic features in 43 patients","volume":"71","author":"Wynne","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.otohns.2004.10.005","article-title":"A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003","volume":"132","author":"Ruda","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0960-7404(99)00037-7","article-title":"Parathyroid cancer: biology and management","volume":"8","author":"Koea","year":"1999","journal-title":"Surg Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/BF01655086","article-title":"Surgical treatment of ten cases of parathyroid carcinoma: importance of an initial en bloc tumor resection","volume":"8","author":"Fujimoto","year":"1984","journal-title":"World J Surg"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib8","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/cncr.22599","article-title":"Trends in the incidence andtreatment of parathyroid cancer in the United States","volume":"109","author":"Lee","year":"2007","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib9","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<538::AID-CNCR25>3.0.CO;2-K","article-title":"Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report","volume":"86","author":"Hundahl","year":"1999","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib10","first-page":"254","article-title":"Dose-response relationships for radiation-induced hyperparathyroidism","volume":"80","author":"Schneider","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1667\/0033-7587(2002)158[0418:DRRFPA]2.0.CO;2","article-title":"Dose-response relationship for parathyroid adenoma after exposure to ionizing radiation in infancy","volume":"158","author":"Holmberg","year":"2002","journal-title":"Radiat Res"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2265.2002.01616.x","article-title":"Increased incidence of parathyroid adenomas following X-ray treatment of benign diseases in the cervical spine in adult patients","volume":"57","author":"Rasmuson","year":"2002","journal-title":"Clin Endocrinol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib13","first-page":"81","article-title":"Primary hyperparathyroidism in patients who have received radiation therapy and in patients who have not received radiation therapy","volume":"180","author":"Tezelman","year":"1995","journal-title":"J Am Coll Surg"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib14","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.ijrobp.2008.06.1487","article-title":"Hyperparathyroidism after irradiation for childhood malignancy","volume":"73","author":"McMullen","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/archinte.1983.00350010083014","article-title":"Clinical, biochemical, and pathologic features of radiation-associated hyperparathyroidism","volume":"143","author":"Katz","year":"1983","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib16","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/bjs.1800750914","article-title":"Hyperparathyroidism after neck irradiation","volume":"75","author":"Christmas","year":"1988","journal-title":"Br J Surg"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib17","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/jcp.38.10.1114","article-title":"Parathyroid carcinoma associated with chronic renal failure and previous radiotherapy to the neck","volume":"38","author":"Ireland","year":"1985","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1288\/00005537-198702000-00015","article-title":"Parathyroid carcinoma: two new cases\u2014diagnosis, therapy, and treatment","volume":"97","author":"Mashburn","year":"1987","journal-title":"Laryngoscope"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib19","first-page":"1006","article-title":"Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome","volume":"108","author":"Jackson","year":"1990","journal-title":"Surgery"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2796.2004.01421.x","article-title":"Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome","volume":"257","author":"Bradley","year":"2005","journal-title":"J Intern Med"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib21","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1046\/j.1365-2796.2003.01168.x","article-title":"Hyperparathyroidism-jaw tumour syndrome","volume":"253","author":"Chen","year":"2003","journal-title":"J Intern Med"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.7326\/0003-4819-107-1-54","article-title":"Familial cystic parathyroid adenomatosis","volume":"107","author":"Mallette","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib23","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nature Genet"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib24","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1128\/MCB.17.3.1160","article-title":"Cdc73p and Paf1p are found in a novel RNA polymerase II-containing complex distinct from the Srbp-containing holoenzyme","volume":"17","author":"Shi","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1365-2796.2009.02107.x","article-title":"Parafibromin\u2014functional insights","volume":"266","author":"Newey","year":"2009","journal-title":"J Intern Med"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/jc.2003-030675","article-title":"Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome","volume":"89","author":"Simonds","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib27","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1136\/jmg.2003.012369","article-title":"Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP)","volume":"41","author":"Villablanca","year":"2004","journal-title":"J Med Genet"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib28","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1210\/jc.2004-0294","article-title":"Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors","volume":"89","author":"Cetani","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib29","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1136\/jmg.2005.032201","article-title":"Utilisation of a cryptic non-canonical donor splice site of the gene encoding PARAFIBROMIN is associated with familial isolated primary hyperparathyroidism","volume":"42","author":"Bradley","year":"2005","journal-title":"J Med Genet"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2265.2006.02460.x","article-title":"Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours","volume":"64","author":"Bradley","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib31","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1210\/jc.2005-1239","article-title":"Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance","volume":"91","author":"Guarnieri","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2265.2006.02534.x","article-title":"Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome","volume":"65","author":"Mizusawa","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib33","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1359\/jbmr.060702","article-title":"Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation","volume":"21","author":"Kelly","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib34","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1677\/ERC-08-0066","article-title":"Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism","volume":"15","author":"Masi","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmg.40.9.657","article-title":"HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours","volume":"40","author":"Howell","year":"2003","journal-title":"J Med Genet"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib36","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1210\/jc.2004-0294","article-title":"Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors","volume":"89","author":"Cetani","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib37","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","article-title":"Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma","volume":"349","author":"Shattuck","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2265.2007.02894.x","article-title":"Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas","volume":"67","author":"Haven","year":"2007","journal-title":"Clin Endocrinol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1677\/ERC-09-0291","article-title":"CDC73\/HRPT2 CpG island hypermethylation and mutation of 5\u2032-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors","volume":"17","author":"Hahn","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib40","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/000348940711601210","article-title":"Aberrant methylation of the HRPT2 gene in parathyroid carcinoma","volume":"116","author":"Hewitt","year":"2007","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/ERC-09-0134","article-title":"Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue","volume":"17","author":"Corbetta","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib42","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1210\/jc.2005-0717","article-title":"HRPT2 mutational analysis of typical sporadic parathyroid adenomas","volume":"90","author":"Krebs","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib43","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1158\/0008-5472.CAN-04-2063","article-title":"Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype","volume":"64","author":"Haven","year":"2004","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib44","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0002-9440(10)64568-3","article-title":"Patterns of chromosomal imbalances in parathyroid carcinomas","volume":"157","author":"Kyt\u00f6l\u00e4","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib45","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/MCB.25.2.612-620.2005","article-title":"The parafibromin tumor suppressor protein is part of a human Paf1 complex","volume":"25","author":"Rozenblatt-Rosen","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/mc.20591","article-title":"The tumor suppressor parafibromin is required for posttranscriptional processing of histone mRNA","volume":"49","author":"Farber","year":"2010","journal-title":"Mol Carcinog"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib47","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.0812023106","article-title":"The tumor suppressor Cdc73 functionally associates with CPSF and CstF 3' mRNA processing factors","volume":"106","author":"Rozenblatt-Rosen","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib48","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.onc.1208274","article-title":"Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1\/PRAD1 expression","volume":"24","author":"Woodard","year":"2005","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib49","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/nar\/gkp991","article-title":"The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression","volume":"38","author":"Yang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib50","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1038\/sj.onc.1210131","article-title":"Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 gene","volume":"26","author":"Zhao","year":"2007","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib51","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1677\/erc.1.01058","article-title":"Loss of parafibromin expression in a subset of parathyroid adenomas","volume":"13","author":"Juhlin","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib52","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/EJE-06-0720","article-title":"Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?","volume":"156","author":"Cetani","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib53","doi-asserted-by":"crossref","first-page":"567","DOI":"10.4158\/EP09045.CRR1","article-title":"Parathyroid carcinoma in multiple endocrine neoplasia type 1 with a classic germline mutation","volume":"15","author":"Shih","year":"2009","journal-title":"Endocr Pract"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1385\/ENDO:12:3:223","article-title":"A newly recognized germline mutation of MEN1 gene identified in a patient with parathyroid adenoma and carcinoma","volume":"12","author":"Sato","year":"2000","journal-title":"Endocrine"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF03347413","article-title":"Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entity","volume":"30","author":"Agha","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib56","doi-asserted-by":"crossref","first-page":"866","DOI":"10.4065\/77.8.866","article-title":"Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: presentation as hypercalcemic crisis","volume":"77","author":"Dionisi","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib57","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1046\/j.1365-2265.1997.3421147.x","article-title":"Metastatic parathyroid carcinoma in the MEN2A syndrome","volume":"47","author":"Jenkins","year":"1997","journal-title":"Clin Endocrinol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib58","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJM199403173301105","article-title":"Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma","volume":"330","author":"Cryns","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib59","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1365-2265.2003.01814.x","article-title":"Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma","volume":"59","author":"Shattuck","year":"2003","journal-title":"Clin Endocrinol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib60","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s002689900567","article-title":"Evaluation of retinoblastoma and Ki-67 immunostaining as diagnostic markers of benign and malignant parathyroid disease","volume":"23","author":"Farnebo","year":"1999","journal-title":"World J Surg"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib61","first-page":"12","article-title":"The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors","volume":"10","author":"Vargas","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib62","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cncr.24037","article-title":"Defining a molecular phenotype for benign and malignant parathyroid tumors","volume":"115","author":"Fernandez-Ranvier","year":"2009","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib63","first-page":"103","article-title":"Absence of p53 point mutations in parathyroid adenoma andcarcinoma","volume":"78","author":"Hakim","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib64","first-page":"1320","article-title":"p53 abnormalities in human parathyroid carcinoma","volume":"78","author":"Cryns","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib65","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0165-4608(98)00049-1","article-title":"Comparative genomic hybridization analysis of human parathyroid tumors","volume":"106","author":"Agarwal","year":"1998","journal-title":"Cancer GenetCytogenet"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib66","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/BF00312388","article-title":"Lung metastasis from parathyroid carcinoma causing recurrent renal hyperparathyroidism in a hemodialysis patient: report of a case","volume":"25","author":"Tominaga","year":"1995","journal-title":"Surg Today"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib67","first-page":"121","article-title":"[Tertiary hyperparathyroidism: parathyroid cancer with liver metastases in a hemodialyzed patient]","volume":"19","author":"Djema","year":"1998","journal-title":"Nephrologie"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib68","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jamcollsurg.2004.04.014","article-title":"Parathyroid carcinoma in secondary and tertiary hyperparathyroidism","volume":"199","author":"Khan","year":"2004","journal-title":"J Am Coll Surg"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib69","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00268-007-9458-8","article-title":"Expression of parafibromin in distant metastatic parathyroid tumors in patients with advanced secondary hyperparathyroidism due to chronic kidney disease","volume":"32","author":"Tominaga","year":"2008","journal-title":"World J Surg"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib70","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/jcem.86.2.7207","article-title":"Clinical review 122: Parathyroid carcinoma","volume":"86","author":"Shane","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib71","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hed.20049","article-title":"Parathyroid carcinoma: a 22-year experience","volume":"26","author":"Busaidy","year":"2004","journal-title":"Head Neck"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib72","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/cncr.22790","article-title":"Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis?","volume":"110","author":"Fernandez-Ranvier","year":"2007","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib73","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ncpendmet0265","article-title":"The diagnosis and management of asymptomatic primary hyperparathyroidism","volume":"2","author":"Silverberg","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib74","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1359\/jbmr.081018","article-title":"Parathyroid carcinoma","volume":"23","author":"Marcocci","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib75","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1477-7819-4-10","article-title":"Normocalcemic parathyroid carcinoma: an unusual clinical presentation","volume":"4","author":"Messerer","year":"2006","journal-title":"World J Surg Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib76","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archsurg.136.8.878","article-title":"Localization and reoperation results for persistent and recurrent parathyroid carcinoma","volume":"136","author":"Kebebew","year":"2001","journal-title":"Arch Surg"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib77","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1210\/jcem-54-1-57","article-title":"Human chorionic gonadotropin subunit measurement in primary hyperparathyroidism","volume":"54","author":"Stock","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib78","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1530\/EJE-08-0169","article-title":"Human chorionic gonadotropin measurements in parathyroid carcinoma","volume":"159","author":"Rubin","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib79","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1373\/clinchem.2007.085506","article-title":"An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1 84) is overproduced in parathyroid carcinoma","volume":"53","author":"Rubin","year":"2007","journal-title":"Clin Chem"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib80","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1507\/endocrj.48.213","article-title":"Ultrasonographic features of parathyroid carcinoma","volume":"48","author":"Hara","year":"2001","journal-title":"Endocr J"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib81","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1089\/thy.2005.15.744","article-title":"Parathyroid carcinoma: ultrasonographic and histologic features","volume":"15","author":"Tamler","year":"2005","journal-title":"Thyroid"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib82","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF03343718","article-title":"Cutaneous spreading of parathyroid carcinoma after fine needle aspiration cytology","volume":"23","author":"Spinelli","year":"2000","journal-title":"J Endocrinol Invest"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib83","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00423-006-0095-8","article-title":"Implantation of parathyroid carcinoma along fine needle aspiration track","volume":"391","author":"Agarwal","year":"2006","journal-title":"Langenbecks Arch Surg"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib84","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11864-001-0028-2","article-title":"Parathyroid carcinoma","volume":"2","author":"Kebebew","year":"2001","journal-title":"Curr Treat Options Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib85","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0002-9610(85)80050-7","article-title":"Natural history of parathyroid carcinoma","volume":"149","author":"Wang","year":"1985","journal-title":"Am J Surg"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib86","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.pap.0000151319.42376.d4","article-title":"Parathyroid carcinoma: an overview","volume":"12","author":"DeLellis","year":"2005","journal-title":"Adv Anat Pathol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib87","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/1097-0142(19900415)65:8<1789::AID-CNCR2820650820>3.0.CO;2-N","article-title":"Flow cytometric DNA analysis of parathyroid tumors with special reference to its diagnostic and prognostic value in parathyroid carcinoma","volume":"65","author":"Obara","year":"1990","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib88","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1507\/endocrj.50.477","article-title":"Double parathyroid carcinoma","volume":"50","author":"Kameyama","year":"2003","journal-title":"Endocr J"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib89","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/SMJ.0b013e318073ca37","article-title":"Multiglandular parathyroid carcinoma: a case report and brief review","volume":"100","author":"Sahasranam","year":"2007","journal-title":"South Med J"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib90","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/1097-0142(197303)31:3<600::AID-CNCR2820310316>3.0.CO;2-0","article-title":"Parathyroid carcinoma","volume":"31","author":"Schantz","year":"1973","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib91","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1158\/1078-0432.CCR-04-0493","article-title":"Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma","volume":"10","author":"Tan","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib92","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/01.pas.0000209827.39477.4f","article-title":"Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias","volume":"30","author":"Gill","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib93","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1677\/ERC-07-0021","article-title":"Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification","volume":"14","author":"Juhlin","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib94","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/jc.2008-1740","article-title":"Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma","volume":"94","author":"Howell","year":"2009","journal-title":"Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib95","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0046-8177(95)90028-4","article-title":"Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining","volume":"26","author":"Abbona","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib96","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00000478-199903000-00007","article-title":"Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein","volume":"23","author":"Erickson","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib97","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/path.1489","article-title":"Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and11q in parathyroid carcinoma","volume":"202","author":"Haven","year":"2004","journal-title":"J Pathol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib98","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.humpath.2005.06.020","article-title":"Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases","volume":"36","author":"Bergero","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib99","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.surg.2007.09.014","article-title":"Functional parathyroid carcinoma: Long-term treatment outcome and risk factor analysis","volume":"142","author":"Iihara","year":"2007","journal-title":"Surgery"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib100","first-page":"481","article-title":"Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas","volume":"34","author":"Juhlin","year":"2009","journal-title":"Int J Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib101","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12105-009-0115-4","article-title":"Non-functional parathyroid carcinoma: a review of the literature and report of a case requiring extensive surgery","volume":"3","author":"Wilkins","year":"2009","journal-title":"Head Neck Pathol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib102","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4158\/EP.13.7.750","article-title":"Nonfunctioning parathyroid carcinoma: case report and review of literature","volume":"13","author":"Fernandez-Ranvier","year":"2007","journal-title":"Endocr Pract"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib103","first-page":"535","article-title":"Immunoperoxidase study of uncommon parathyroid tumors","volume":"7","author":"Ordonez","year":"1983","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib104","first-page":"279","article-title":"Immunohistological study of nonfunctional parathyroid carcinoma","volume":"42","author":"Yamashita","year":"1992","journal-title":"Acta Pathol Jpn"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib105","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0002-9610(85)80050-7","article-title":"Natural history of parathyroid carcinoma","volume":"149","author":"Wang","year":"1985","journal-title":"Am J Surg"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib106","first-page":"1040","article-title":"Surgical and medical management of patients with pulmonary metastasis from parathyroid carcinoma","volume":"114","author":"Obara","year":"1993","journal-title":"Surgery"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib107","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2169\/internalmedicine.33.697","article-title":"Successful treatment by surgical removal of bone metastasis producing PTH: new approach to the management of metastatic parathyroid carcinoma","volume":"33","author":"Koyano","year":"1994","journal-title":"Intern Med"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib108","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00000658-198104000-00006","article-title":"Surgical resection of metastatic parathyroid carcinoma","volume":"193","author":"Flye","year":"1981","journal-title":"Ann Surg"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib109","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF01655520","article-title":"Localization and surgical resection of metastatic parathyroid carcinoma","volume":"10","author":"Fujimoto","year":"1986","journal-title":"World J Surg"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib110","first-page":"657","article-title":"A case report of 20 lung radiofrequency ablation sessions for 50 lung metastases from parathyroid carcinoma causing hyperparathyroidism","volume":"33","author":"Tochio","year":"2010","journal-title":"Radiol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib111","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1200\/JCO.2007.15.9038","article-title":"Metastatic parathyroid carcinoma to the liver treated with radiofrequency ablation and transcatheter arterial embolization","volume":"26","author":"Artinyan","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib112","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1590\/S0004-27302008000400019","article-title":"Ethanol injection under ultrasound guidance to palliate unresectable parathyroid carcinoma","volume":"52","author":"Montenegro","year":"2008","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib113","first-page":"1132","article-title":"Parathyroid carcinoma: biochemical and pathologic response to DTIC","volume":"96","author":"Calandra","year":"1984","journal-title":"Surgery"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib114","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archinte.1984.00350140229032","article-title":"Successful combination chemotherapy for metastatic parathyroid carcinoma","volume":"144","author":"Bukowski","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib115","first-page":"106","article-title":"Intravenous pamidronic acid in hypercalcemia due to parathyroid carcinoma","volume":"51","author":"Vega","year":"1991","journal-title":"Medicina (B Aires)"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib116","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ncpendmet0189","article-title":"A case of parathyroid carcinoma with hypercalcemia responsive to cinacalcet therapy","volume":"2","author":"Szmuilowicz","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib117","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1210\/jcem.83.4.4726","article-title":"Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent","volume":"83","author":"Collins","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib118","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1210\/jc.2007-0585","article-title":"Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma","volume":"92","author":"Silverberg","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib119","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0140-6736(98)06469-1","article-title":"Control of hypercalcaemia of parathyroid carcinoma by immunisation","volume":"353","author":"Bradwell","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib120","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1210\/jc.2003-031911","article-title":"Hormonal and biochemical normalization and tumor shrinkage induced by antiparathyroid hormone immunotherapy in a patient with metastatic parathyroid carcinoma","volume":"89","author":"Betea","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib121","first-page":"1551","article-title":"Cancer-induced hypercalcemia","volume":"29","author":"Lumachi","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib122","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/BF02067369","article-title":"Prognostic factors in parathyroid cancer: a review of 95 cases","volume":"16","author":"Sandelin","year":"1992","journal-title":"World J Surg"},{"key":"10.1053\/j.seminoncol.2010.10.013_bib123","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/000313480306900909","article-title":"Resection of pulmonary metastasis from parathyroid carcinoma","volume":"69","author":"Hundley","year":"2003","journal-title":"Am Surg"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775410001831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775410001831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:53:19Z","timestamp":1758804799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775410001831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":123,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0093775410001831"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2010.10.013","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parathyroid Cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminoncol.2010.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}